The current valuation score of United Therapeutics Corp is 8.60, ranking 80 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 18.60, which is 6.87% below the recent high of 19.87 and 46.64% above the recent low of 9.92.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.